Psychopharmacology of comorbid obsessive-compulsive disorder and depression

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 8, 1997, Pages 17-19

  Den Boer, Johan A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

COMORBIDITY; CONFERENCE PAPER; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DYSPHORIA; HUMAN; OBSESSION; PRIORITY JOURNAL; RATING SCALE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

COMORBIDITY; DEPRESSIVE DISORDER; FLUOXETINE; FLUVOXAMINE; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS;

EID: 0030786337     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Gittleson NL. Depressive psychosis in the obsessional neurotic. Br J Psychiatry 1966;112:153-159
2. Kendell RE, DiScipio WJ. Obsessional symptoms and obsessional personality traits in patients with depressive illnesses. Br J Psychiatry 1980;136:1-25
3. Rasmussen SA, Tsuang MT. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry 1986;143: 317-322
4. Demal U, Lenz G, Mayrhofer A, et al. Obsessive-compulsive disorder and depression. Psychopathology 1993;26:145-150
5. Marks I. Are there anticompulsive or antiphobic drugs: review of the evidence. Br J Psychiatry 1983;143:338-347
6. Mallya GK, White K, Waternaux C, et al. Short and long-term treatment of obsessive compulsive disorder. Ann Clin Psychiatry 1992;4:77-80
7. Perse TL, Greist JH, Jefferson W, et al. Fluvoxamine treatment of obsessive-compulsive disorder. Am J Psychiatry 1987;144:1543-1548
8. Jenike MA, Hyman S, Baer L, et al. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Am J Psychiatry 1990;147:1209-1215
9. Goodman WK, Price LH, Delgado PL, et al. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: comparison of fluvoxamine and desipramine. Arch Gen Psychiatry 1990;47: 577-585
10. Goodman WK, Kozak MJ, Liebowitz M, et al. Treatment of obsessive compulsive disorder with fluvoxamine: a multicentre double-blind placebo-controlled trial. Int Clin Psychopharmacol 1996;11(1):21-29
11. Goodman WK, Price LH, Rasmussen SA, et al. Efficacy of fluvoxamine in obsessive-compulsive disorder: a double-blind comparison with placebo. Arch Gen Psychiatry 1989;46:36-44
12. Greist JH, Jenike M, Robinson D, et al. Efficacy of fluvoxamine in obsessive compulsive disorder: results of a multicentre double-blind placebo-controlled trial. Eur J Clin Res 1995;7:195-204
13. Freeman ChPL, Trimble MR, Deakin JWF, et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicentre randomized double-blind parallel group comparison. J Clin Psychol 1994;55:301-305
14. Tollefson GD, Rampey AH, Potvin JH, et al. A multicentre investigation of fixed-dose fluoxetine in the treatment of obsessive compulsive disorder. Arch Gen Psychiatry 1994;51:559-567
15. Montgomery SA, McIntyre A, Osterheider M, et al. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. Eur Neuropsychopharmacol 1993;3:143-152
16. Pigott TA, Pato MT, Bernstein SE, et al. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: behavioral and biological results. Arch Gen Psychiatry 1990;47: 926-932
17. Riddle MA, Scahill L, King RA, et al. Double-blind trial of fluoxetine and placebo in children and adolescents with obsessive compulsive disorder. J Am Acad Child Adolesc Psychiatry 1992;31:1062-1069
18. Zohar J, The OCD Study Group. A double-blind study to assess the efficacy and tolerance of paroxetine compared with clomipramine and placebo in the treatment of obsessive compulsive disorder. Poster presented at the 7th congress of the Association of European Psychiatrists; 1994; Copenhagen, Denmark
19. Jenike MA, Baer L, Summergrad P, et al. Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo. Am J Psychiatry 1990;147:923-928
20. Chouinard G, Goodman W, Greist J, et al. Results of a double-blind placebo-controlled trial of a new serotonin reuptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull 1990; 26:279-284